Radiotherapy can lead to ICD and the release of high migration group box 1 protein (HMGB-1); HMGB-1 binds to Toll-like receptor-4 (TLR-4), participates in the progression and presentation of tumor antigens, and promotes the activation and maturation of DCs. The gene discussed is HMGB1; the disease is neoplasm.